Characterization of extracellular matrix deposited by segmental trabecular meshwork cells.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
12 Mar 2023
12 Mar 2023
Historique:
entrez:
22
3
2023
pubmed:
23
3
2023
medline:
23
3
2023
Statut:
epublish
Résumé
Biophysical and biochemical attributes of the extracellular matrix are major determinants of cell fate in homeostasis and disease. Ocular hypertension and glaucoma are diseases where the trabecular meshwork tissue responsible for aqueous humor egress becomes stiffer accompanied by changes in its matrisome in a segmental manner with regions of high or low flow. Prior studies demonstrate these alterations in the matrix are dynamic in response to age and pressure changes. The underlying reason for segmentation or differential response to pressure and stiffening are unknown. This is largely due to a lack of appropriate models (
Identifiants
pubmed: 36945588
doi: 10.1101/2023.03.11.532242
pmc: PMC10028995
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NEI NIH HHS
ID : R01 EY030238
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY019643
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY032590
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY025721
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC002368
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY008247
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA069533
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY010572
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026048
Pays : United States
Commentaires et corrections
Type : UpdateIn
Références
Exp Eye Res. 2020 Aug;197:108046
pubmed: 32376472
J Cell Physiol. 2022 Jul;237(7):3012-3029
pubmed: 35567755
Exp Eye Res. 2017 May;158:67-72
pubmed: 27334250
PLoS One. 2015 Mar 31;10(3):e0122483
pubmed: 25826404
Proteomics. 2013 Jan;13(1):22-4
pubmed: 23148064
Acta Biomater. 2023 Apr 1;160:98-111
pubmed: 36822485
Transl Vis Sci Technol. 2020 Sep 15;9(10):16
pubmed: 32983624
Exp Eye Res. 2022 Jan;214:108891
pubmed: 34896309
J Cell Sci. 2003 Jan 15;116(Pt 2):217-24
pubmed: 12482908
Exp Eye Res. 2018 Jun;171:164-173
pubmed: 29526795
Exp Eye Res. 2018 Jun;171:106-110
pubmed: 29535003
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12856-12867
pubmed: 32439707
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4447-59
pubmed: 26193921
J Biol Chem. 2017 Sep 1;292(35):14425-14437
pubmed: 28710283
Invest Ophthalmol Vis Sci. 2011 Oct 21;52(11):8287-94
pubmed: 21917933
J Cell Sci. 2018 Mar 1;131(5):
pubmed: 29361522
Exp Eye Res. 1993 Jun;56(6):683-92
pubmed: 8595810
Exp Eye Res. 2022 Mar;216:108935
pubmed: 35033558
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6197-6211
pubmed: 29222550
Exp Eye Res. 2022 Dec;225:109285
pubmed: 36273576
J Cataract Refract Surg. 2014 Aug;40(8):1263-72
pubmed: 25088623
J Cell Sci. 2012 Jul 1;125(Pt 13):3015-24
pubmed: 22797912
Trends Biochem Sci. 2021 Aug;46(8):652-660
pubmed: 33573881
Sci Rep. 2017 Oct 30;7(1):14329
pubmed: 29085025
Acta Biomater. 2018 Apr 15;71:444-459
pubmed: 29524673
Ophthalmic Res. 2001 Nov-Dec;33(6):314-24
pubmed: 11721183
Exp Eye Res. 1986 May;42(5):443-55
pubmed: 3720863
ACS Biomater Sci Eng. 2015 Feb 9;1(2):110-118
pubmed: 30882039
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10339-10349
pubmed: 32341164
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1068-76
pubmed: 11923248
Arch Ophthalmol. 1997 Mar;115(3):375-83
pubmed: 9076211
J Mech Behav Biomed Mater. 2014 Sep;37:209-18
pubmed: 24951927
Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6482-6495
pubmed: 27918822
Cold Spring Harb Perspect Biol. 2011 Dec 01;3(12):
pubmed: 21917992
Proc Natl Acad Sci U S A. 2019 Dec 26;116(52):26555-26563
pubmed: 31806762
Sci Rep. 2020 Sep 24;10(1):15641
pubmed: 32973273
Cytokine Growth Factor Rev. 1999 Jun;10(2):99-117
pubmed: 10743502
Methods Mol Biol. 2009;522:103-21
pubmed: 19247601
Invest Ophthalmol Vis Sci. 2011 Apr 05;52(5):2147-52
pubmed: 21220561
Invest Ophthalmol Vis Sci. 2011 Jul 07;52(8):5049-57
pubmed: 21596823
Nat Cell Biol. 2006 May;8(5):492-500
pubmed: 16604063
J Ocul Biol Dis Infor. 2009 Dec 12;2(4):223-234
pubmed: 20157357
Exp Eye Res. 2003 Dec;77(6):757-65
pubmed: 14609564
Am J Pathol. 2006 Feb;168(2):574-84
pubmed: 16436671
Int J Mol Med. 1998 Feb;1(2):339-46
pubmed: 9852235
Exp Eye Res. 2009 Apr;88(4):752-9
pubmed: 18977348
Ann Biomed Eng. 2020 Jul;48(7):2103-2112
pubmed: 31745676
Invest Ophthalmol Vis Sci. 2006 Jan;47(1):226-34
pubmed: 16384967
Methods Mol Biol. 2009;563:123-40
pubmed: 19597783
Prog Retin Eye Res. 2021 May;82:100897
pubmed: 32795516
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Methods Cell Biol. 2020;156:271-307
pubmed: 32222223
Anal Biochem. 1995 Dec 10;232(2):158-62
pubmed: 8747470
Prog Retin Eye Res. 2017 May;58:89-114
pubmed: 28223208
Exp Eye Res. 2020 Jan;190:107888
pubmed: 31786158
J Endocrinol. 2011 May;209(2):139-51
pubmed: 21307119
J Biochem. 1978 Oct;84(4):933-5
pubmed: 711705
Mass Spectrom Rev. 2020 May;39(3):229-244
pubmed: 28691345
J Rheumatol Suppl. 1991 Feb;27:49-51
pubmed: 2027130
Invest Ophthalmol Vis Sci. 2014 Jul 15;55(8):4922-33
pubmed: 25028360
Exp Eye Res. 2008 Apr;86(4):543-61
pubmed: 18313051
Bone. 2015 Oct;79:190-5
pubmed: 26079997
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):246-259
pubmed: 29340639
Exp Eye Res. 1986 May;42(5):457-65
pubmed: 3720864
BMC Syst Biol. 2017 May 16;11(1):55
pubmed: 28511648
Nat Rev Mol Cell Biol. 2019 Aug;20(8):457-473
pubmed: 31182865
Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):24
pubmed: 32305042
Ophthalmic Res. 2007;39(6):330-7
pubmed: 18046086